EGFR Resisters is excited to partner with Lung Cancer Research Foundation to raise funds for new EGFR-positive lung cancer research project(s). EGFR Resisters (https://egfrcancer.org) has worked since our founding in 2017 to identify gaps in research and critical needs for our patient community. We have proven the power of patient driven research and are again ready to raise money to fund more projects that will address the important questions that we face.
Our goal is to raise $75,000 to be matched dollar for dollar by LCRF in order to fund a full two year grant specific to EGFR research. This means your support will go twice as far toward supporting an investigator who otherwise may have seen their work go unfunded.
LCRF has a history of funding the best researchers in the field. Including Dr. Matthew Meyerson from Dana-Farber Cancer Institute, whose early work, funded through LCRF, led his group to discover the EGFR mutations in lung cancer, setting the stage for the field of genome-targeted therapy.
Join us in continuing to provide support for our community through advancing research together!